Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement
2023-11-01 to 2024-10-31
Revenue by End Markets
2023-11-01 to 2024-10-31
Swipe to see the full flow
Chart details
Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement
Income statement for 2023-11-01 through 2024-10-31. View: End Markets. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Net revenue
- 6,510,000,000 US dollars
- Cost of revenue
- 2,975,000,000 US dollars
- Gross profit (calculated)
- 3,535,000,000 US dollars
- Operating expenses (calculated)
- 2,047,000,000 US dollars
- Income from operations
- 1,488,000,000 US dollars
- Other income (expense), net (calculated)
- 33,000,000 US dollars
- Income before taxes, as reported
- 1,521,000,000 US dollars
- Provision for income taxes
- 232,000,000 US dollars
- Net Income
- 1,289,000,000 US dollars
- Pharmaceutical and Biopharmaceutical Market
- 2,242,000,000 US dollars
- Chemical and Advanced Materials Market
- 1,495,000,000 US dollars
- Diagnostics and Clinical Market
- 964,000,000 US dollars
- Food Market
- 592,000,000 US dollars
- Academia and Government Market
- 567,000,000 US dollars
- Environmental and Forensics Market
- 650,000,000 US dollars
- Research and development
- 479,000,000 US dollars
- Selling, general and administrative
- 1,568,000,000 US dollars
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
54.3%
Gross profit / revenue
Operating margin
22.9%
Operating profit / revenue
Cash conversion
135.8%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
